DC-806

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameDC-806
Drug Alias NameS-011806DC-806LY-4100504
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-17 inhibitors
TargetsInterleukin-17
Therapy Area/IndicationsPlaque psoriasisPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaUnited States +[9
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesDice Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesDice Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsPlaque psoriasis
Inactive IndicationsPsoriasis

Other Information

ATC CodeN/A
Related LinksN/A